Académique Documents
Professionnel Documents
Culture Documents
Komplemen
Pe Sekresi Histamin
Virus DEN
Ensim PLA 2
Makrofag
Metabolisme
As Arakhidonat
Jalur Siklooksigenase
Leokotrien
Membuka Celah
Protasiklin
Endotel kapiler
Tromboksan
Prostaglandin E-2
Virus DEN
Aktifasi Gen
NF-kB
Makrofag
Produksi & Sekresi
Sitokin Proinflamatori
Plasma Leakage
Virus DEN
Makrofag
Sintesis NO
Pe Kelenturan
Dinding Kapiler
ROS
Plasma Leakage
Transmission Cycle
NOISAKRAN AND PERNG
Clinical manifestation
• Asymptomatic
• Dengue fever
• Dengue hemorrhagic
fever
• Dengue shock syndrome
Risk Factors For Dengue
Haemorrhagic Fever
Natural Course of DHF
• Fever 2 – 7 Days
• Critical Period 24 – 48 hrs
Plasma leakage
Abnormal hemostasis
• Convalescence 3 – 7 Days
Dengue fever
Acute febrile illness with two or more of the following
– Headache, retro-orbital pain, myalgia,
arthralgia, rash, hemorrhagic manifestation,
leukopenia
Lab for confirmation
– Isolation of dengue virus, fourfold rising in
reciprocal IgG or IgM, PCR (genomic
sequence), immunostaining (dengue
antigen)
Dengue hemorrhagic fever
• Fever (last 2-7 days), occasionally biphasic
• Hemorrhagic tendency
– Tourniquet test, petechiae, bleeding from mucosa
• Thrombocytopenia (< 100,000 cell/mm3)
• Evidence of plasma leakage
– Hct increase >20%, Hct drop >20% after
volume replacement, pleural effusion, ascites,
hypoproteinaemia
Dengue shock syndrome
• Tourniquet test
• CBC PPV = 70-80%
Tourniquet test positive + leucopenia*
= Dengue infection
*Leucopenia = wbc 5,000 cells/cumm
• At least day 3 of fever
• CBC everyday if possible
• Close follow up until 24 hours of defervescence
Tourniquet Test
Fever day 1
50%
Fever day 2 70%
Fever day 3 > 90%
False negative TT
• Obese patients
• Thin patients
• Not good technique
• During shock
Prolonged shock
• > 10 hours untreated - Death!!!
• > 4 hours untreated
Liver failure- prognosis 50%